NDC 58468-0426

Nexviazyme 100 mg per 10 mL injection, powder, lyophilized, for solution

On the label: Genzyme Corporation.

United States: 2Belgium: 1Ireland: 1

Where it's made

FactoryWhereRoleLast FDA inspection
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme CorporationFramingham, MA, United StatesMakes the active ingredient and tests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action
Genzyme FlandersGeel, BelgiumMakes the active ingredient and tests it Problems found, fixed voluntarilySep 25, 2024 · 9 inspections
Genzyme Ireland LimitedWaterford, IrelandMakes it, tests it, packages it and labels it Problems found, fixed voluntarilyFeb 25, 2022 · 7 inspections
Eurofins Biopharma Product Testing Ireland LimitedIrelandTests it Problems found, fixed voluntarilyMay 26, 2023 · 5 inspections
Genzyme CorporationNorthborough, MA, United StatesPackages it and labels it No problems foundAug 14, 2025 · 6 inspections
Genzyme CorporationFramingham, MA, United StatesTests it Problems found, fixed voluntarilyApr 9, 2026 · 9 inspections, 1 with FDA action

Product details

Generic drug
Avalglucosidase Alfa: every company that makes it
Form
injection, powder, lyophilized, for solution, intravenous
Strength
100 mg per 10 mL
Approval
BLA BLA761194
On the market since
Aug 6, 2021
Package NDCs
58468-0426-1
Official label
DailyMed (National Library of Medicine), updated Jun 5, 2025

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?